dc.contributor.author | Bateman, Brian Thomas | |
dc.contributor.author | Shaw, Kate M. | |
dc.contributor.author | Kuklina, Elena V. | |
dc.contributor.author | Callaghan, William M. | |
dc.contributor.author | Seely, Ellen Wells | |
dc.contributor.author | Hernández-Díaz, Sonia | |
dc.date.accessioned | 2013-03-13T17:45:49Z | |
dc.date.issued | 2012 | |
dc.identifier.citation | Bateman, Brian T., Kate M. Shaw, Elena V. Kuklina, William M. Callaghan, Ellen W. Seely, and Sonia Hernández-Díaz. 2012. Hypertension in women of reproductive age in the United States: NHANES 1999-2008. PLoS ONE 7(4): e36171. | en_US |
dc.identifier.issn | 1932-6203 | en_US |
dc.identifier.uri | http://nrs.harvard.edu/urn-3:HUL.InstRepos:10399829 | |
dc.description.abstract | Objective: To examine the epidemiology of hypertension in women of reproductive age. Methods: Using NHANES from 1999–2008, we identified 5,521 women age 20–44 years old. Hypertension status was determined using blood pressure measurements and/or self-reported medication use. Results: The estimated prevalence of hypertension in women of reproductive age was 7.7% (95% confidence interval (CI): 6.9%–8.5%). The prevalence of anti-hypertensive pharmacologic therapy was 4.2% (95% CI 3.5%–4.9%). The prevalence of hypertension was relatively stable across the study period; the age and race adjusted odds of hypertension in 2007–2008 did not differ significantly from 1999–2000 (odds ratio 1.2, CI 0.8 to 1.7, p = 0.45). Significant independent risk factors associated with hypertension included older age, non-Hispanic black race (compared to non-Hispanic whites), diabetes mellitus, chronic kidney disease, and higher body mass index. The most commonly used antihypertensive medications included diuretics, angiotensin-converting enzyme inhibitors (ACE), and beta blockers. Conclusion: Hypertension occurs in about 8% of women of reproductive age. There are remarkable differences in the prevalence of hypertension between racial/ethnic groups. Obesity is a risk factor of particular importance in this population because it affects over 30% of young women in the U.S., is associated with more than 4 fold increased risk of hypertension, and is potentially modifiable. | en_US |
dc.language.iso | en_US | en_US |
dc.publisher | Public Library of Science | en_US |
dc.relation.isversionof | doi:10.1371/journal.pone.0036171 | en_US |
dc.relation.hasversion | http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3340351/pdf/ | en_US |
dash.license | LAA | |
dc.subject | Medicine | en_US |
dc.subject | Cardiovascular | en_US |
dc.subject | Cardiovascular Diseases in Women | en_US |
dc.subject | Hypertension | en_US |
dc.subject | Epidemiology | en_US |
dc.subject | Cardiovascular Disease Epidemiology | en_US |
dc.subject | Pharmacoepidemiology | en_US |
dc.subject | Non-Clinical Medicine | en_US |
dc.subject | Health Care Policy | en_US |
dc.subject | Health Education and Awareness | en_US |
dc.subject | Health Risk Analysis | en_US |
dc.subject | Nutrition | en_US |
dc.subject | Obesity | en_US |
dc.subject | Obstetrics and Gynecology | en_US |
dc.subject | Pregnancy | en_US |
dc.subject | Hypertensive Disorders in Pregnancy | en_US |
dc.subject | Pregnancy Complications | en_US |
dc.subject | Public Health | en_US |
dc.subject | Health Screening | en_US |
dc.subject | Preventive Medicine | en_US |
dc.subject | Women's Health | en_US |
dc.title | Hypertension in Women of Reproductive Age in the United States: NHANES 1999-2008 | en_US |
dc.type | Journal Article | en_US |
dc.description.version | Version of Record | en_US |
dc.relation.journal | PLoS ONE | en_US |
dash.depositing.author | Bateman, Brian Thomas | |
dc.date.available | 2013-03-13T17:45:49Z | |
dc.identifier.doi | 10.1371/journal.pone.0036171 | * |
dash.contributor.affiliated | Seely, Ellen | |
dash.contributor.affiliated | Bateman, Brian | |